PA
SKINW

Parallel Advisors’s The Beauty Health Company Warrant expiring 5/4/2026 SKINW Stock Holding History

Parallel Advisors’s Portfolio SKINW Stock Details SKINW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-214
Closed -$1K – 3385
2021
Q2 		$1K Buy
+214
New +$918 ﹤0.01% 2899

Other funds holding SKINW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Parallel Advisors's SKINW Position: Q3 2021 in Review

Parallel Advisors sold out of The Beauty Health Company Warrant expiring 5/4/2026 (SKINW) in Q3 2021, closing a stake of 214 shares — an estimated $1K sold.

Parallel Advisors first reported a position in SKINW in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 31 funds tracked by Wall St. Rank hold SKINW as of Q3 2021.

  • Parallel Advisors reported no remaining The Beauty Health Company Warrant expiring 5/4/2026 position as of Q3 2021 after selling out during the quarter.
  • Parallel Advisors sold 214 The Beauty Health Company Warrant expiring 5/4/2026 shares in Q3 2021, an estimated $1K.
  • Parallel Advisors first reported a position in The Beauty Health Company Warrant expiring 5/4/2026 in Q2 2021 and held it in 1 quarter.
  • Parallel Advisors's The Beauty Health Company Warrant expiring 5/4/2026 position peaked at $1K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held The Beauty Health Company Warrant expiring 5/4/2026 as of Q3 2021.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.